Jared M Newman1, Nipun Sodhi2, Alyeesha B Wilhelm3, Anton Khlopas2, Alison K Klika2, Qais Naziri1, Thomas J Kryzak2, Carlos A Higuera2, Michael A Mont4. 1. Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, USA. 2. Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, USA. 3. St. Georges University School of Medicine, True Blue, Grenada. 4. Department of Orthopaedic Surgery, Lenox Hill Hospital, 100 East 77th Street, New York, NY, 10075, USA. rhondamont@aol.com.
Abstract
PURPOSE: Therefore, the purpose of this study was to evaluate the short-term perioperative outcomes of PD patients who underwent total knee arthroplasty (TKA). We specifically evaluated: (1) perioperative surgical and medical complications; (2) lengths of stay (LOS); and (3) total hospital charges. METHODS: The Nationwide Inpatient Sample was used to identify PD patients who underwent TKA between 2002 and 2013. To control for potential confounders, PD TKA and non-PD TKA patients were propensity score matched (1:3) based on age, sex, ethnicity, Charlson Comorbidity Index, and insurance type. A total of 31,979 PD and 95,596 non-PD TKA patients were included. RESULTS: PD patients had a 44% higher risk of suffering from any complication (OR 1.44; 95% CI 1.35-1.54), a 45% increased risk for any medical complication (OR 1.45; 95% CI 1.36-1.55), and a 9% higher risk for any surgical complication (OR 1.09; 95% CI 0.84-1.41). Compared to the matched cohort, PD patients had a mean LOS that was 6.5% longer (95% CI 5.46-7.54) and mean total hospital charges that were 3.05% higher (95% CI 1.99-4.11). CONCLUSIONS: PD patients are more likely to have postoperative complications, longer LOS, and higher costs after TKA than non-PD TKA patients. Since many of these complications can be prevented, a team-based multi-specialty patient optimization is needed. LEVEL OF EVIDENCE: Level III, therapeutic study.
PURPOSE: Therefore, the purpose of this study was to evaluate the short-term perioperative outcomes of PDpatients who underwent total knee arthroplasty (TKA). We specifically evaluated: (1) perioperative surgical and medical complications; (2) lengths of stay (LOS); and (3) total hospital charges. METHODS: The Nationwide Inpatient Sample was used to identify PDpatients who underwent TKA between 2002 and 2013. To control for potential confounders, PD TKA and non-PD TKA patients were propensity score matched (1:3) based on age, sex, ethnicity, Charlson Comorbidity Index, and insurance type. A total of 31,979 PD and 95,596 non-PD TKA patients were included. RESULTS:PDpatients had a 44% higher risk of suffering from any complication (OR 1.44; 95% CI 1.35-1.54), a 45% increased risk for any medical complication (OR 1.45; 95% CI 1.36-1.55), and a 9% higher risk for any surgical complication (OR 1.09; 95% CI 0.84-1.41). Compared to the matched cohort, PDpatients had a mean LOS that was 6.5% longer (95% CI 5.46-7.54) and mean total hospital charges that were 3.05% higher (95% CI 1.99-4.11). CONCLUSIONS:PDpatients are more likely to have postoperative complications, longer LOS, and higher costs after TKA than non-PD TKA patients. Since many of these complications can be prevented, a team-based multi-specialty patient optimization is needed. LEVEL OF EVIDENCE: Level III, therapeutic study.
Entities:
Keywords:
Complications; Cost; Lengths of stay; Parkinson’s disease; Total knee arthroplasty
Authors: Cynthia L Leibson; Demetrius M Maraganore; James H Bower; Jeanine E Ransom; Peter C O'brien; Walter A Rocca Journal: Mov Disord Date: 2006-04 Impact factor: 10.338
Authors: Mary E Charlson; Robert E Charlson; Janey C Peterson; Spyridon S Marinopoulos; William M Briggs; James P Hollenberg Journal: J Clin Epidemiol Date: 2008-07-10 Impact factor: 6.437
Authors: Marcus C Mueller; Ulf Jüptner; Ullrich Wuellner; Stefan Wirz; Andreas Türler; Andreas Hirner; Jens Standop Journal: Langenbecks Arch Surg Date: 2008-08-19 Impact factor: 3.445
Authors: Hind A Beydoun; Sharmin Hossain; Shuyan Huang; May A Beydoun; Brook T Alemu; Shaker M Eid; Alan B Zonderman Journal: Psychosom Med Date: 2021-06-01 Impact factor: 3.864